Keith Lamont Cummings, Chief Financial Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 19,920 shares at $26.52 ($528K) on 2023-03-30, disclosed to the SEC on 2023-04-03.
Scheduled sale ($528k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.52 | 9,960 | $264K | 50.0% |
| 2 | $26.52 | 9,960 | $264K | 50.0% |
| Total | $26.52 avg | 19,920 | $528K | 100% |
| Filing → |
| PLRX | SELL | 2024-07-12 | $252K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $337K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $712K | — | Filing → |